Management strategies for reflux disease are very different from those for dyspepsia and so differentiating between patients with “true” dyspepsia and those whose primary symptom is heartburn is a key step in their management. This separation has become more clear during the last decade as insights into reflux disease and dyspepsia have improved. It is likely that the use of short self administered questionnaires in routine clinical care will improve the reliability of separation of reflux induced symptoms from true dyspepsia.
- reflux disease
Statistics from Altmetric.com
Conflict of interest: This symposium was sponsored by AstraZeneca, makers of omeprazole. The author of this paper has received sponsorship for travel and an honorarium from AstraZeneca.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.